USANA Health Sciences Statistics Share Statistics USANA Health Sciences has 18.27M
shares outstanding. The number of shares has increased by -2.25%
in one year.
Shares Outstanding 18.27M Shares Change (YoY) -2.25% Shares Change (QoQ) -1.49% Owned by Institutions (%) 56.43% Shares Floating 10.93M Failed to Deliver (FTD) Shares 2 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 796.77K, so 4.28% of the outstanding
shares have been sold short.
Short Interest 796.77K Short % of Shares Out 4.28% Short % of Float 7.39% Short Ratio (days to cover) 7.14
Valuation Ratios The PE ratio is 16.19 and the forward
PE ratio is 8.49.
USANA Health Sciences's PEG ratio is
-0.48.
PE Ratio 16.19 Forward PE 8.49 PS Ratio 0.8 Forward PS 0.5 PB Ratio 1.28 P/FCF Ratio 13.36 PEG Ratio -0.48
Financial Ratio History Enterprise Valuation USANA Health Sciences has an Enterprise Value (EV) of 527.64M.
EV / Sales 0.62 EV / EBITDA 5.34 EV / EBIT 8.65 EV / FCF 10.36
Financial Position The company has a current ratio of 2,
with a Debt / Equity ratio of 0.05.
Current Ratio 2 Quick Ratio 1.5 Debt / Equity 0.05 Debt / EBITDA 0.29 Debt / FCF 0.57 Interest Coverage 236.03
Financial Efficiency Return on Equity is 7.9% and Return on Invested Capital is 5.73%.
Return on Equity 7.9% Return on Assets 5.62% Return on Invested Capital 5.73% Revenue Per Employee $502.65K Profits Per Employee $24.72K Employee Count 1,700 Asset Turnover 1.14 Inventory Turnover 2.31
Taxes Income Tax 34.29M Effective Tax Rate 44.91%
Stock Price Statistics The stock price has increased by -21.73% in the
last 52 weeks. The beta is 0.61, so USANA Health Sciences's
price volatility has been higher than the market average.
Beta 0.61 52-Week Price Change -21.73% 50-Day Moving Average 30.74 200-Day Moving Average 32.11 Relative Strength Index (RSI) 40.16 Average Volume (20 Days) 149,441
Income Statement In the last 12 months, USANA Health Sciences had revenue of 854.5M
and earned 42.03M
in profits. Earnings per share was 2.2.
Revenue 854.5M Gross Profit 693.29M Operating Income 66.32M Net Income 42.03M EBITDA 98.86M EBIT 76.63M Earnings Per Share (EPS) 2.2
Full Income Statement Balance Sheet The company has 181.77M in cash and 29.01M in
debt, giving a net cash position of 152.75M.
Cash & Cash Equivalents 181.77M Total Debt 29.01M Net Cash 152.75M Retained Earnings 478.94M Total Assets 734.53M Working Capital 140.24M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 60.99M
and capital expenditures -10.07M, giving a free cash flow of 50.92M.
Operating Cash Flow 60.99M Capital Expenditures -10.07M Free Cash Flow 50.92M FCF Per Share 2.67
Full Cash Flow Statement Margins Gross margin is 81.13%, with operating and profit margins of 7.76% and 4.92%.
Gross Margin 81.13% Operating Margin 7.76% Pretax Margin 8.94% Profit Margin 4.92% EBITDA Margin 11.57% EBIT Margin 7.76% FCF Margin 5.96%
Dividends & Yields USNA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 6.18% FCF Yield 7.48%
Dividend Details Analyst Forecast The average price target for USNA is $36,
which is 22.8% higher than the current price. The consensus rating is "Hold".
Price Target $36 Price Target Difference 22.8% Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $11 Lynch Upside -62.48% Graham Number 37.21 Graham Upside 26.91%
Stock Splits The last stock split was on Nov 23, 2016. It was a
forward
split with a ratio of 2:1.
Last Split Date Nov 23, 2016 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 3.87 Piotroski F-Score 5
